NCT02998099View on ClinicalTrials.gov

A Study to Evaluate the Effect of Age on the Pharmacokinetics, Safety and Tolerability of IV Rivipansel.

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

February 28, 2017

Study Completion Date

March 31, 2017

Conditions
Healthy
Interventions
DRUG

Rivipansel

A single dose of IV rivipansel over 20 minutes.

Trial Locations (1)

32809

Orlando Clinical Research Center, Orlando

All Listed Sponsors
lead

GlycoMimetics Incorporated

INDUSTRY

NCT02998099 - A Study to Evaluate the Effect of Age on the Pharmacokinetics, Safety and Tolerability of IV Rivipansel. | Biotech Hunter | Biotech Hunter